Bristol-Myers Squibb
(BMY:
sentiment,
chart,
options)
may have been the focus of a short straddle on Tuesday. According to data from WhatsTrading.com, the security saw some heavy option trading, with more than 126,400 contracts changing hands. This volume was more than seven times the equity's average daily trading volume of 17,386 contracts.
In the July series, the stock's 22-strike call added approximately 7,000 new positions, pushing its open interest up to 10,712 contracts. At 12:14 p.m. Eastern time, the security saw a block of 6,250 contracts traded at $0.03, while another block of 750 contracts changed hands at $0.03. Both trades were between the bid and ask prices at the time.
Meanwhile, the July 22 put also added approximately 7,000 new positions, resulting in open interest of more than 8,700 contracts. At 12:14 p.m., a block of 6,250 contracts traded at a bid price of $2.10, while another block of 750 contracts changed hands at a bid price of $2.10.
In a short straddle, a trader collects a net credit when the trade is initiated and expects the stock to close right at the sold strike so that both options expire worthless, allowing him to retain the entire premium.
Overall, options players are relatively skeptical of the shares. The Schaeffer's put/call open interest ratio for BMY stands at 0.65, which is higher than 83% of all those taken during the past year. In other words, short-term options players have been more skeptical of the shares only 17% of the time during the past 12 months.